In this study, twice-daily exenatide treatment was associated with a lower risk of CVD events including MI, ischemic stroke, or coronary revascularization procedure (hazard ratio [HR], 0.81
Resident microglia are considered part of the NVU due to their capacity to modulate BBB function in response to changes associated with various conditions
SYNCRIP interacts with the SIRT1 promoter to modulate gene transcription
I have been tracking data and decided to do a deep dive going back 5 yrs (Dec 2020 - Jan 2026) to see what I find
Dual-component blend: GHRH-R agonist (CJC-1295, Modified GRF 1-29) + GHSR-1a agonist pentapeptide (Ipamorelin) The pathways CJC / IPA Blend acts on and what each one does
Beyond appetite control and weight loss, GLP-1s may also support heart, kidney, liver, and brain healthand potentially even reduce addictive behaviors